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Background: The normal accumulation of adult α and β globins in definitive erythrocytes is critically dependent
upon processes that ensure that the cognate mRNAs are maintained at high levels in transcriptionally silent, but
translationally active progenitor cells. The impact of these post-transcriptional regulatory events on the expression
of embryonic ζ globin is not known, as its encoding mRNA is not normally transcribed during adult erythropoiesis.
Recently, though, ζ globin has been recognized as a potential therapeutic for α thalassemia and sickle-cell disease,
raising practical questions about constitutive post-transcriptional processes that may enhance, or possibly prohibit,
the expression of exogenous or derepresssed endogenous ζ-globin genes in definitive erythroid progenitors.
Methods: The present study assesses mRNA half-life in intact cells using a pulse-chase approach; identifies cis-acting
determinants of ζ-globin mRNA stability using a saturation mutagenesis strategy; establishes critical 3′UTR secondary
structures using an in vitro enzymatic mapping method; and identifies trans-acting effector factors using an affinity
chromatographical procedure.
Results: We specify a tetranucleotide 3′UTR motif that is required for the high-level accumulation of ζ-globin
transcripts in cultured cells, and formally demonstrate that it prolongs their cytoplasmic half-lives. Surprisingly, the
ζ-globin mRNA stability motif does not function autonomously, predicting an activity that is subject to structural
constraints that we subsequently specify. Additional studies demonstrate that the ζ-globin mRNA stability motif is
targeted by AUF1, a ubiquitous RNA-binding protein that enhances the half-life of adult β-globin mRNA, suggesting
commonalities in post-transcriptional processes that regulate globin transcripts at all stages of mammalian development.
Conclusions: These data demonstrate a mechanism for ζ-globin mRNA stability that exists in definitive erythropoiesis
and is available for therapeutic manipulation in α thalassemia and sickle-cell disease.
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Human α-like globins are encoded by three homologous
genes (5′-ζ-α2-α1-3′) arranged in order of their develop-
mental expression [1]. Embryonic α-like ζ globin is
produced during the first gestational trimester in primitive
erythroblasts that originate in blood islands of the yolk sac,
while fetal/adult α globin is induced at the end of this
interval and continues to express in definitive erythroblasts
that are initially produced in the liver and, subsequently, in
the bone marrow [1,2]. Unlike α globin–which is required* Correspondence: jeruss@mail.med.upenn.edu
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unless otherwise stated.for normal growth and development both in the uterus
and after birth–ζ globin appears to be largely dispensable
to mammalian reproduction. Embryonic ζ globin is not
required for viability in mice [3], and naturally occurring
deletions and duplications in its encoding gene are not
associated with any defined phenotype in man [2,4,5]. As a
consequence of this apparent biological irrelevance, then,
there has been little incentive to detail the processes that
control ζ-globin expression in either primitive or definitive
erythropoiesis.
Investigations of the molecular and cellular programs
that regulate ζ globin, though, are recently justified by its
demonstrated potential as a novel therapeutic for both α
thalassemia and sickle-cell disease [6,7]. When compelled
to express in definitive erythroid cells, embryonic ζ globinThis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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ζ2β2 (Hb Portland-2), which exhibits O2-binding and
allosteric properties that differ modestly from those of Hb
α2β2 (Hb A, the principal adult hemoglobin), but that
remain fully compatible with normal adult physiology
[8,9]. The significance of this approach for treating α-
globin deficiency states (α thalassemia) is illustrated by
evidence that transgenic human ζ globin fully reverts the
pathological phenotype of mice containing heterozygous
knockout of their endogenous α-globin genes and,
remarkably, restores full viability to animals with homozy-
gous, embryonic-lethal inactivation of these same genes
[6]. The developmental stage-discordant expression of ζ
globin holds additional therapeutic promise for sickle-cell
disease, as its low-level expression effectively mitigates the
abnormal phenotype of mouse models of this disorder
[7,10]. Importantly, the α→ ζ exchange that converts
pathological Hb α2β
S
2 (Hb S) to non-pathological Hb ζ2β
S
2
does not exclude the mutant βS subunit, raising the possi-
bility that this novel strategy can be coordinated with con-
temporary therapies that promote βS→ γ exchange. These
two developing applications for ζ globin–effected through
either gene-reactivation or gene-supplementation strategies–
now recommend careful description of the events that con-
tribute to its regulation in definitive erythroid cells.
Post-transcriptional regulatory processes are critical to
the normal accumulation of adult α- and β-globins in de-
finitive erythrocytes, ensuring that the cognate mRNAs are
maintained at high levels in transcriptionally silent–but
translationally active–progenitor cells. The fundamental
bases for the prolonged half-life (t1/2) values for both α-
and β-globin mRNAs have now been established in detail,
including the identification of specific trans-acting effector
proteins and the cis-acting regulatory elements that they
target [11-16]. Similar analyses of embryonic ζ-globin
transcripts that are expressed either physiologically or
following therapeutic derepression in definitive erythropoi-
esis indicate that the mRNAs are subject to post-
transcriptional processes that are constitutive to these cells
[17,18]. While ζ-globin mRNA is observed at low levels in
normal adult erythroid progenitors [19-21], it can accumu-
late to significantly higher levels in cells where its encoding
gene is transcriptionally dysregulated [22-24], implicating
the presence of active post-transcriptional processes that
are capable of acting upon developmental stage-discordant
ζ-globin mRNA. Transgenic human ζ globin can also be
produced in abundance in adult mice (at levels that sup-
port viability in α-globin nullizygotes) [6], validating the
assertion that–as a practical matter–the half-life of its
encoding mRNA is sufficiently long to ensure that biologic-
ally relevant levels of ζ globin are translated [6-9]. These
principles are confirmed in individuals with Southeast
Asian-type α thalassemia [25], congenital dyserythropoietic
anemia [26], and juvenile chronic myelocytic leukemia[24], who express measurable quantities of both ζ-globin
mRNA and ζ-globin protein. Collectively, these observa-
tions endorse the likelihood that post-transcriptional
programs in adult erythropoiesis are fully permissive for
the expression of ζ-globin mRNA.
The present work describes structures within the ζ-
globin 3′UTR that are critical to its post-transcriptional
regulation, illustrates their effects on the half-life value of
the full-length ζ-globin mRNA in intact cells, and identifies
a trans-acting factor that is likely to mediate this process.
These results provide a foundation for understanding the
impact of post-transcriptional activities to the developmen-
tal stage-discordant expression of ζ globin in adult erythro-
poiesis, as a promising therapeutic for both α thalassemia
and sickle-cell disease.
Results
A transcriptional chase strategy identifies cis-acting
regulatory determinants within the ζ-globin 3′UTR
Transgenic human ζ globin accumulates to high levels in
mouse erythrocytes, consistent with the existence of cis-
acting determinants that stabilize the cognate ζ-globin
mRNA in transcriptionally silent progenitor cells [6,7,18].
Precedent analyses of both globin and non-globin mRNAs
indicate that relevant stability determinants are commonly
confined to the 3′ region of untranslated mRNA (3′UTR),
which is not subject to disruption by translating ribosomes
[27-31]. We investigated the likely positioning of an mRNA
stability element in the ζ-globin 3′UTR in a systematic
manner, employing a linker-scanning strategy to identify
cis-acting determinants of mRNA half-life that act in vivo
in intact cells. Full-length ζ-globin genes were constructed
to include either the 105-nt wild-type ζ-globin 3′UTR
(ζWT); or identically sized variant ζ-globin 3′UTRs, each
containing an 8-nt mutation at a different position between
the UGA translational termination codon and the polyade-
nylate tail (Figure 1). Each gene was linked to a recombin-
ant hybrid tetracycline response element (TRE) that
promotes transcription in cultured cells expressing a hy-
brid tetracycline trans-activating protein (tTA), but is tran-
scriptionally silent in the presence of tetracycline (tet) [32].
This approach permitted half-life values for wild-type and
3′UTR-variant ζ-globin mRNAs to be specified in vivo in
tTA-expressing cells, using a transcriptional chase strategy
that assesses the temporal reduction in the level of each
variant ζ-globin mRNA relative to the steady-state level of
a tet-indifferent control mRNA [33,34].
To identify the positions of mRNA stability determinants
within the ζ-globin 3′UTR, we conducted a screening assay
that quantified the relative decay of wild-type and 3′UTR-
variant ζ-globin mRNAs in vivo in intact cultures. Mam-
malian cultured-cell models for erythroid development
transcribe a variety of embryonic, fetal, and adult globin
mRNAs that can compete for post-transcriptional
Figure 2 Relative decay of transiently expressed wild-type and
3′UTR-variant ζ-globin mRNAs in vivo. Values correspond to the
quantity of each ζ-globin mRNA remaining after a 16-hr transcriptional
chase interval, relative to transiently co-expressed β-globin mRNA. The
relative decay of ζWT mRNA was arbitrarily assigned unit value. Each
bar represents the mean ± SD value from between two and six replicates.
The relative decay of ζARE mRNA, which contains an mRNA-destabilizing
element within its 3′UTR [33,37], was assessed in all experiments as a
methodological control. (A) Relative decay of 3′UTR-variant ζ-globin
mRNAs carrying octanucleotide mutations. Asterisks indicate p values for
each mRNA, relative to ζ57 mRNA (* < 0.02; ** < 0.005; *** < 0.001).
(B) Relative decay of 3′UTR-variant ζ-globin mRNAs carrying tetranucleotide
mutations in the initial (ζ57.1-4) or terminal (ζ57.5-8) four nucleotides of the
nt 57–64 motif (left), or smaller mutations in the first (ζ57.1-2) or second
(ζ57.3-4) dinucleotide of this region.
Figure 1 Primary structures of mRNAs encoded by wild-type and 3′UTR-variant ζ-globin mRNAs. Native and mutated regions of each 3′
UTR sequence are denoted in uppercase and lowercase bold, respectively. The UGA termination codon and AAUAAA polyadenylation signal are
boxed; the polyadenylate tail is indicated as (An). The tetranucleotide motif that confers stability to the ζWT mRNA is highlighted in gray.
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our studies in tTA-expressing HeLa cells (HeLatTA) that do
not transcribe globin mRNAs and have previously been
used to characterize post-transcriptional processes affecting
both native and exogenous globin genes [16,34]. We tested
the relative decays of transiently expressed ζWT and 3′
UTR-variant ζ-globin mRNAs, relative to that of a control
β-globin mRNA transcribed from a co-transfected gene,
using a two-point decay method of our design. One of the
3′UTR-variant mRNAs–containing a CCCCAGCC→ agtg-
caCa substitution at nts 57–64 (ζ57 mRNA)–reproducibly
decayed over a 16-hour interval to a level that was approxi-
mately one-third that of ζWT mRNA (Figure 2A). The ef-
fect of the octanucleotide substitution was dependent upon
its position rather than its content, as ζ-globin mRNAs con-
taining a similar mutation elsewhere in the 3′UTR–includ-
ing flanking nts 49–56 and 65–72 (ζ49 and ζ65 mRNAs,
respectively)–decayed at the same rate as parental ζWT
mRNA. The mutational effects were consistent over three
or more replicate analyses, thus identifying and localizing a
previously unknown post-transcriptional determinant of
mRNA decay within the ζ-globin 3′UTR. For convenience,
we now term the nt 57–64 region the ζ-globin mRNA regu-
latory element (ZMRE).
We posited that the kinetics of ζ-globin mRNA decay
might be similarly affected by a smaller defect in the nt
57–64 target region, according with precedent studies
demonstrating the deleterious effects of site-specific
single- or several-nt 3′UTR substitutions on the stabilities
of both α- and β-globin mRNAs [16,18,38]. This hypoth-
esis was validated by transcriptional chase analyses of
transiently expressed ζ-globin mRNAs carrying tetranu-
cleotide substitutions at either positions 1–4 or 5–8 of the
ζ57 target region (ζ57.1-4 and ζ57.5-8 mRNAs, respect-
ively; CCCCAGCC→ agtgAGCC and CCCCAGCC→
CCCCcaCa). While the relative decay of ζ57.5-8 mRNA
was no different from ζWT mRNA (Figure 2B, left), the
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to a similar extent as that of parental ζ57 mRNA. Subse-
quent analyses demonstrated that smaller, dinucleotide
substitutions to the nt 57–64 region did not affect mRNA
decay, indicating that the ZMRE is functionally permissive
for mutations of this magnitude (Figure 2B, right). Collect-
ively, these screening data specify the importance of a
site-specific tetranucleotide motif to the regulated accu-
mulation of ζ-globin mRNA.
The ZMRE regulates the half-life of ζ-globin mRNA
Results from two-point screening analyses indicated the
likelihood that the ζ57 determinant is essential for nor-
mal accumulation of ζ-globin mRNA in cell cytoplasm.
We validated this hypothesis by formally assessing t1/2
values for wild-type and informative 3′UTR-variant ζ-globin
mRNAs in vivo. Analyses were conducted in triplicate in
transiently transfected HeLatTA cells using a conventional
pulse-chase strategy that assesses the levels of test mRNAs
at defined intervals, relative to the level of endogenous tet-
indifferent β-actin mRNA [33]. Under these conditions, the
ζ57 mRNA displayed a t1/2 value that was approximately
one-fourth that of ζWT mRNA (3.7 v 15.4 hr, respectively),
while ζ49 and ζ65 mRNAs–containing ZMRE-flanking
mutations–displayed relatively normal t1/2 values of 11.6
and 10.2 hr (Figure 3). These data were affirmed byFigure 3 Half-life values for 3′UTR-variant ζ-globin mRNAs. Transiently
mRNA assessed at defined intervals relative to levels of endogenous tet-indiff
point is plotted relative to the normalized level at t = 0, which is arbitrarily ass
three replicates. (A) Stable control ζWT mRNA. (B) ζ57 mRNA. (C) ζ49 mRNA.
for curves in panels A-E, calculated from best-fit exponential decay curves witsubsequent analyses demonstrating the deleterious effect
the ζ57.1-4 mutation (but not the ζ57.5-8 mutation) on the
half-life of ζ-globin mRNA (Figure 4). In these latter studies,
the t1/2 value of control ζWT mRNA (11.2 hr) was reduced
to the same extent by either full (ζ57) or partial (ζ57.1-4)
substitution of the nt 57–64 target region (3.6 and 3.7 hr,
respectively), confirming the centrality of the CCCC tetra-
nucleotide to ZMRE function. Additional pulse-chase
studies–conducted in cells that stably express wild-type and
3′UTR-variant ζ-globin mRNAs–revealed similar results
(not shown), providing a third measure of experimental
validation. Collectively, the transcriptional chase analyses
agree on the positioning of a post-transcriptional regulatory
element within the ζ57 region, as well on its critical import-
ance to the constitutive half-life of ζ-globin mRNA.
The mRNA-stabilizing activity of the ZMRE is not
autonomous
Previous analyses in transgenic mice demonstrated that the
stability of human α-globin mRNA was significantly
reduced when its 3′UTR was exchanged for the corre-
sponding region of ζ-globin mRNA [18]. This effect was
originally attributed to a generic difference in then-
unspecified determinants of α- and ζ-globin half-life [17]
and, later, to sequence dissimilarities between homologous
pyrimidine-rich regulatory elements within the α- and ζ-transfected HeLatTA cells were amended with tet, and levels of ζ-globin
erent β-actin mRNA. The normalized level of ζ-globin mRNA at each time
igned unit value. Each point depicts the mean ± SD value for at least
(D) ζ65 mRNA. (E) Unstable control ζARE mRNA. (F) Half-life and R2 values
h a fixed value of 1.0 at t = 0.
Figure 4 Half-life values for ζ57-derivative globin mRNAs. Stability analyses were conducted on informative ζ-globin mRNAs as described in
Figure 3. (A) Stable control ζWT mRNA. (B) ζ57 mRNA. (C) ζ57.1-4 mRNA. (D) ζ57.5-8 mRNA. (E) Half-life and R2 values for curves in panels A-D,
calculated from best-fit exponential decay curves.
Figure 5 Relative decay of transiently expressed βζ-chimeric
mRNAs in HeLatTA cells. (A) Structures of mRNAs encoded by
chimeric βζ-globin genes; regions derived from β- and ζ-globin
sequence are indicated in black and white, respectively. The positions
of the translation initiation (I) and termination (T) sites, as well as the
polyadenylate tail (An), are indicated. The ζ57, ζ57.1-4, ζ49, and ζ65
mutations are illustrated in gray. The 3′UTR of the βζARE mRNA contains
a defined 59-nt adenosine/uridine-rich element, inserted 15 nts 3′ to the
translation stop codon; this motif destabilizes the full-length transcript,
providing an unstable mRNA that is used as a methodological control
[33]. RD = relative decay values obtained using the experimental strategy
described in Figure 3.
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nately arise from a ZMRE function that was highly sensitive
to its regional mRNA structural context; i.e., that the regu-
latory properties of the ZMRE might be reduced when
repositioned near heterologous mRNA. To test this possi-
bility, we assessed whether the half-life of a reporter
coding-region mRNA contiguous with the ζ57 3′UTR
would be reduced relative to an identical mRNA flanked by
a ζWT 3′UTR (Figure 5A). A two-point decay analysis indi-
cated that the stabilities of 3′UTR-chimeric β-globin
mRNAs were indifferent to the presence of stabilizing
(ζWT) or destabilizing (ζ57 and ζ57.1-4) 3′UTRs, validating
an activity for the ZMRE that is dependent upon its RNA
context (Figure 5B). While it is difficult to generalize this
effect to coding regions from all mRNAs, our observations
suggest that the activity of the ZMRE is defined both by its
primary structure (Figures 3 and 4) as well as by undefined
effects of neighboring mRNA and/or mRNA-bound factors
(Figure 5).
The ZMRE maps to a region of ζ-globin 3′UTR that
displays conformational flexibility
The observation that the ζ-globin mRNA is destabilized
by mutations within the ZMRE, but not by similar muta-
tions in neighboring cytosine-rich regions, suggests a
local high-order structure that favors functional interac-
tions between the ZMRE and one or more trans-actingeffector factors. An unrefined m-fold analysis of ζ-globin
3′UTR structure predicts that the ZMRE is embedded
in a highly stable RNA stem, and directly participates in
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were skeptical that this arrangement would support site-
specific interactions with regulatory RNA-binding pro-
teins, and consequently employed an enzymatic mapping
technique to formally characterize the high-order RNA
structure that encompasses the ZMRE [41]. Our analyses
revealed regions of ζ-globin 3′UTR that–by virtue of
their sensitivities to single- and double-strand-specific
RNases–were inconsistent with the unrefined structure
(Figure 6B). A subsequent m-fold analysis, constrained
by unequivocal, experimentally determined regions of
single- and double-stranded interactions, predicted an al-
ternate structure with a favorable ΔGo value (−26.3 kcal/
mol) in which the nt 57–64 target region is positioned on
an asymmetrical interior loop, contiguous to a 16-nt stem
(Figure 6C). This arrangement–which would be expected
to facilitate conformational flexibility in the regions of
RNA that flank the ZMRE [42]–would also account for
our observation that transitional nucleotides (bordering
the base-paired and unpaired regions) are assigned
double-stranded interactions but display modest sensitivities
to single-strand nucleases (e.g., C57 and C58). The resist-
ance of the cytosine-rich ZMRE to double-strand-specific
RNase V may additionally suggest potential hydrophobic
‘stacking’ interactions that can serve as a target for trans-act-
ing regulatory factors [43]. The structural dynamics of this
region, combined with experimental evidence favoring itsFigure 6 High-order structure of the ζ-globin 3′UTR. (A) A thermodyna
the full-length ζ-globin 3′UTR (detail). The ZMRE is indicated in boldface. D
thick connectors, respectively. (B) Enzymatic secondary-structure mapping
to the ζ-globin 3′UTR (and contiguous 18-nt polyadenylate tail) were diges
(wedges), then resolved on an acrylamide-urea gel. Nucleotide assignment
specific bands corresponding to guanine bases (lane G), which were gener
ladder (lanes A) provides additional sequence information at single-nucleo
characteristics (i.e., sensitivities to double- and single-strand-specific nuclease
structure resulting from m-fold analysis of the full-length ζ-globin 3′UTR, whe
for nts 29–34 (detail). Nucleotides that displayed less-exacting single- or doub
indicated by s and d, respectively.assembly, indicates that the positioning of the ZMRE may
be critical to its regulatory function.
Cytoplasmic mRNA-binding proteins interact with the
ZMRE
The stabilities of many mRNAs–including those encoding
α globin [27], β globin [16], α(I) collagen [28], tyrosine
hydroxylase [29], histone [30], and the transferrin receptor
[31]–require the assembly of defined mRNP effector com-
plexes on specific determinants within their 3′UTRs. To
identify candidate trans-acting factors that might func-
tionally interact with the ZMRE, we conducted affinity
chromatography analyses on cell extracts from both
non-erythroid HeLa and erythroid K562 cells, using
three 32-nt single-stranded (ss) DNAs corresponding to
comparable regions of ζ57, control ζWT, and control
ζ65 3′UTRs. Both the control ζWT and ζ65 ssDNAs
retained fewer than 10 distinct factors–two of which
were not retained by the ζ57 ssDNA–suggesting site-
specific trans-acting interactions and potential regulatory
functions (Figure 7A). Excised bands were subjected to
nanoLC/MS/MS and provisionally identified as isoforms of
AUF1 (hnRNP D), a protein that is ubiquitously expressed
[44], displays known mRNA-binding characteristics [45,46],
participates in post-transcriptional regulatory events that
effect both mRNA stabilization [47] and destabilization
[48], and has been implicated as a determinant of β-mically favored structure resulting from unrefined m-fold analysis of
ouble and triple hydrogen bond interactions are indicated by thin and
of the ζ-globin 3′UTR (detail). 5′-end [32P]-labeled RNAs corresponding
ted with RNases A, T1, and V1 at four different concentrations
s (right) were deduced by aligning the known 3′UTR sequence to
ated by RNase T1 digestion of denatured 3′UTRs. An alkaline hydrolysis
tide resolution. Regions of 3′UTR that exhibit stem- and loop-like
s, respectively) are indicated to the left. (C) Thermodynamically favored
re base-pairing is enforced for nts 20–21, 24–26, and 38; and prohibited
le-strand characteristics were not used for predictive purposes but are
Figure 7 Affinity-enrichment analyses for ZMRE-binding factors. (A) SDS-PAGE of retentate from ζWT, ζ57, and ζ65 ssDNA probes, and from
control agarose beads. Bands corresponding to two AUF1 isotypes are indicated with an asterisk. M =molecular size marker. (B) Confirmatory
immunoblot analyses. Retentate was assessed using antibodies against AUF1, RPA70 (positive control, binds all three probes), and hnRNP H
(negative control, present in input nuclear and cytoplasmic fractions). Similar results were obtained in parallel analyses of extracts from HeLa cells
(not shown). (C) RNA immunoprecipitation analyses. Experiments were conducted on extract from HeLa cells that express ζ-globin mRNA, using
AUF1 antibody or control polyspecific immunoglobulin (Ig) control. c-Myc mRNA was assessed in parallel as a positive control for AUF1 binding.
M =molecular size marker; C = water-only RT-PCR control; I = control input (unprecipitated) mRNA.
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relative affinities for ζWT, ζ57, and specificity-control ζ65
3′UTRs–was subsequently validated by immunoblot ana-
lyses of the three retentates (Figure 7B). Additional analyses
demonstrated that AUF1 immunoprecipitate of extract pre-
pared from ζWT-expressing HeLatTA cells is enriched for
both ζWT and positive control c-myc mRNAs (Figure 7C),
demonstrating the assembly of ζ-globin/AUF1 mRNPs
in vivo. These results document the interaction of AUF1
with the ZMRE and provide an attractive mechanistic link
between the structure of the ζ-globin 3′UTR and its
mRNA-stabilizing functions. The importance of AUF1 to
this process also suggests that the half-life of ζ-globin
mRNA may be regulated in definitive erythropoiesis
through post-transcriptional programs that act on other
mRNAs, including β-globin mRNA, that are central to
normal red cell development.
Discussion
Recent reports that ζ globin acts as a physiological sur-
rogate for deficient α globin [8,9] and efficiently inhibits
the pathological polymerization of deoxyHb S [7,10]
have engendered substantial interest in developing this
embryonic globin as a unique and highly effective thera-
peutic for α thalassemia and sickle-cell disease, respect-
ively. The premise that developmentally silenced globin
genes can be derepressed in definitive erythroid cells is
consistent with observations that ζ globin is expressed at
high levels in several congenital and acquired conditions
in humans [24-26] and can be reactivated by mutations
that target transcriptional regulatory elements in animals
[22-24]. Developmental stage-discordant embryonic glo-
bins can also be expressed from transgenes that have
been modified to contain adult-stage promoters andenhancers [6,17,22]. While the specific mechanisms that
underlie transcriptional repression of embryonic globin
genes in definitive erythropoiesis remain a matter of active
investigation, it is clear that this process can be reversed
in adult erythroid progenitors.
An equally important determinant of ζ-globin expre
ssion–its post-transcriptional regulation–has been studied
less extensively in both primitive and definitive erythropoi-
esis. Processes that impart high stability to globin mRNAs
are particularly important in adult erythroblasts, permitting
these transcripts to accumulate to high levels and to trans-
late globin protein for 3–5 days following nuclear condensa-
tion and extrusion from orthochromatophilic erythroblasts
[1]. As might be predicted, mutations that impair the high
stabilities of globin mRNAs in transcriptionally silent cells
will disproportionately impact the levels of their encoded
proteins. For example, a naturally occurring antitermination
mutation that shortens the t1/2 of α-globin mRNA to ~25%
of its normal value (αConstant Spring) coordinately reduces
expression of the cognate globin monomer to ~2% of the
wild-type value [49,50]. Without some knowledge of the
half-life of ζ-globin mRNA, on the mechanism through
which it is stabilized in definitive erythroid cells, it is difficult
to predict whether transcriptional derepression of the ζ-
globin gene transcription will necessarily achieve the desired
therapeutic effect.
We previously observed a modest difference in the
stabilities of human α-and ζ-globin mRNAs that were
compelled to express in definitive mouse erythroid cells
[18]. This effect, which mapped to single-nt differences
in homologous pyrimidine-rich elements (PREs) posi-
tioned within the two 3′UTRs, was attributed to a 6-fold
reduction in the affinity of the ζ-PRE for αCP (hnRNP E),
a cytoplasmic mRNA-binding protein that effects the high
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mRNA was not fully stabilized by exchange of the ζ-PRE
for the corresponding α-globin determinant, suggesting
the activities of other, structurally dissimilar mRNA-
stabilizing elements [18]. The present study validates this
hypothesis, as it identifies a unique site-specific region of
3′UTR that is essential for the normal cytoplasmic accu-
mulation of ζ-globin (Figures 1 and 2). Subsequent half-life
analyses, conducted in vivo in intact cultured cells, directly
demonstrate the importance of the ZMRE (and, specific-
ally, its 4-nt cytosine-rich core) to the cytoplasmic stability
of ζ-globin mRNA (Figures 3 and 4).
Our several measures suggest a t1/2 value of 11–15 hr
for ζ-globin mRNA in HeLa cells (Figures 3 and 4),
which is surprisingly close to a t1/2 value of ~11 hr for
α-globin mRNA obtained in MEL cells using a similar
strategy [50]. The similar stabilities of α- and ζ-globin
mRNAs in these cultured cells–which do not express
other globin mRNAs in significant quantities–contrasts
sharply with their discordant stabilities in primary
mouse cells that co-express high levels of endogenous α-
globin mRNA [18]. The cell context-dependent differ-
ence in the relative stabilities of the α- and ζ-globin
mRNAs suggests that they may be co-regulated through
a shared post-transcriptional mechanism. We previously
described a similar relationship among developmentally
related β-like globin mRNAs, where the stabilities of
transgenic embryonic ε- and fetal γ-globin mRNAs are
reduced in the presence of adult β-globin mRNA [35,36].
A similar relationship between the ζ- and α-globin
mRNAs would account for the significant reduction in the
half-life of ζ-globin mRNA when co-expressed with α-
globin mRNA of either human or mouse origin. The im-
plications of this mechanism vis-à-vis α thalassemia are
substantial, as expression of ζ-globin mRNA from a thera-
peutic transgene would self-correct to higher or lower
levels in patients with more or less severe deficits in α-
chain production, respectively.
Our results also indicate that the stability of ζ-globin
mRNA in definitive erythropoiesis reflects a balance
between at least two separate post-transcriptional pro-
grams. The ZMRE that we identify is distinct from the
previously identified ζ-PRE in both its position within
the 3′UTR as well as the specific trans-acting factors
that it binds (Figure 7). Specifically, the ZMRE binds
AUF1, a trans-acting mRNA-binding protein implicated
in both the stabilization and destabilization of heterol-
ogous mRNAs in erythroid and non-erythroid cells
[16,47,48]. This interaction may account for the observa-
tion that ZMRE-related activities are readily observed in
non-erythroid HeLa cells (Figures 3 and 4), while αCP-
mediated programs that stabilize α-globin mRNA are
largely restricted to erythroid cells [11]. Importantly,
AUF1 stabilizes β-globin mRNA through interactionwith a 3′UTR determinant [16], suggesting potential
mechanistic overlap between programs that direct the
stabilities of α-like and β-like mRNAs or, conceivably,
the stabilities of embryonic and adult globin mRNAs.
Both possibilities would be consistent with dynamic
post-transcriptional competition between embryonic and
adult globin transcripts [36] and would predict that the
efficiency of ζ-globin derepression in α thalassemia would
be proportional to the severity of the α-chain deficit.
One remarkable property of the ZMRE is its apparent
non-autonomous function (Figure 5), suggesting ‘allo-
steric’ effects of surrounding structures on the activity of
this determinant (Figure 6). While our studies do not
investigate the positions of these function-modifying
structures, we think it unlikely that they reside in coding
region mRNA which is constantly remodeled by actively
translating ribosomes. It seems reasonable to speculate
that ZMRE activity is instead enforced by interactions
with other regions of 3′UTR (or factors that they bind), or
by structural interface with the ζ-globin 5′UTR. The latter
process might resemble the ‘closed-loop’ model for mRNA
translation that invokes structural interactions between
the 5′UTR, 3′UTR, and polyadenylate tail [51-55]. The
experimentally determined structure surrounding the
ZMRE is fully consistent with this possibility (Figure 6),
predicting its positioning on an internal loop and/or
within a hydrophobic nucleotide stack, where effector
trans-acting factors might bind and subsequently alter the
regional structure to reveal (or conceal) co-determinants
of mRNA stability.
Conclusion
Collectively, the present studies address the relevance of
post-transcriptional regulatory events to ζ-globin expres-
sion in definitive erythroid cells, by defining structures
and implicating mechanisms of ζ-globin mRNA stability.
Our functional analyses identify a previously unrecognized
determinant of mRNA stability within the ζ-globin 3′UTR
whose position can be narrowed to a 4-nt site-specific
cytosine sequence. Coordinate structural studies recognize
that this region maps to a functionally germane mRNA
form that is targeted by trans-acting regulatory factors
that have been previously been implicated in stabilizing
both globin and non-globin mRNAs. This information
provides a foundation for subsequent mechanistic studies
that will be critical for understanding the full utility of de-
velopmental stage-discordant ζ-globin mRNA as a thera-
peutic for important disorders of globin gene expression.
Methods
Gene construction
Parental pTRE2Aζ was derived from pTRE2 (Clontech)
by inserting the full-length human ζ-globin gene (includ-
ing ~100 nt of contiguous 5′- and 3′-flanking regions)
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SapI vector fragment was subsequently deleted to elim-
inate a default polyadenylation signal that competes with
the native ζ-globin poly(A) signal. 3′UTR-derivative ζ-
globin genes were constructed from pTRE2Aζ by exchan-
ging the exon III BstEII-polylinker BamHI fragment with
330-bp synthetic DNAs (Genscript), each encompassing a
mutated ζ-globin 3′UTR. The construction of a corre-
sponding full-length β-globin gene (pTRE2Aβ) is de-
scribed elsewhere [15]. Genes encoding chimeric βζ-
globin mRNAs were generated from pTRE2Aβ by exchan-
ging the parental EcoRI-EcoNI DNA fragment (encom-
passing β-globin exon III and contiguous 3′-flanking
region) for a corresponding synthetic DNA containing the
desired wild-type or derivative ζ-globin 3′UTR. All recom-
binant DNAs were validated by automated sequencing.
Cell culture
HeLatTA cells expressing the tetracycline transactivator fu-
sion protein (tTA; Clontech) were maintained in DMEM
supplemented with 10% FBS and antibiotics, at 37°C in a
humidified 5% CO2 environment. Wild-type and 3′UTR-
derivative pTRE2Aζ vectors used for stable transfections
were modified by inserting a 1.5-kb DNA fragment encod-
ing hygromycin (hyg) resistance into a unique vector XhoI
site. Approximately 6×105 cells were transfected with
5.0 μg of DNA using Superfect reagent under conditions
recommended by the manufacturer (Qiagen), and selected
with 400 μg/mL hyg. Hyg-resistant clones were tested by
RT-qPCR for levels of ζ-globin mRNA and control en-
dogenous β-actin mRNA. Tetracycline (tet) response was
assessed by quantifying the level of ζ-globin mRNA, rela-
tive to the level of tet-indifferent β-actin mRNA, following
a 48-hr incubation in tet-supplemented media (2 μg/mL).
mRNA decay analyses
Two-point decay analyses were conducted on 5×105 pre-
plated HeLatTA cells maintained in tet-supplemented
medium (0.5 μg/mL). Cells were transfected with 5.0 μg
DNA comprising equal quantities of wild-type (or 3′
UTR-derivative) TRE2Aζ and control pTRE2Aβ using
Superfect reagent, and replated as two aliquots for over-
night growth in tet-supplemented medium (0.03 μg/mL).
PBS-washed aliquots were then incubated for five hr in
tet-free medium; one aliquot was sacrificed immediately
(t = 0) and a second aliquot after an additional 16-hr in-
cubation in tet-supplemented medium (2.0 μg/mL). Con-
ventional half-life analyses were conducted on 2×106
HeLatTA cells maintained in tet-supplemented medium
(0.5 μg/mL), transfected with 10 μg DNA using Superfect
reagent, and then replated in aliquots in tet-supplemented
medium (0.03 μg/mL) for overnight growth. PBS-washed
aliquots were then incubated in tet-free medium for five
hr, supplemented with tet (2.0 μg/mL) and sacrificed atdefined intervals. For both transient and stable analyses,
cells were sacrificed by immersion in Trizol, and RNA
prepared as recommended by the manufacturer (Invitro-
gen). Purified RNA was resuspended at 10 μg/mL in H2O,
and stored at −80°C.
RT-qPCR
Purified RNA (50 ng) was assayed using Taqman One-
Step reagents on a model 7500 real-time PCR system,
using protocols recommended by the manufacturer (Ap-
plied Biosystems; AB). Analyses were conducted using as-
says for human ζ globin (AB catalogue HS00923579_m1),
β globin (HS00747223_g1), and β actin (HS9999990
3_m1), and quantified by ΔΔCt methodology that we de-
scribe elsewhere [34]. Relative decay values were calcu-
lated as the quantity of each ζ-globin mRNA remaining
after a 16-hr transcriptional chase interval, relative to
transiently co-expressed β-globin mRNA; the relative
decay of ζWT mRNA was arbitrarily assigned unit value.
p values–where indicated–were calculated using standard
Student t-test methods.
Affinity enrichment
Custom 5′-terminal biotinylated single-strand (ss) DNAs
corresponding to 3′UTRs from ζWT (5′TGGAGGTTCCC
CAGCCCCACTTACCGCGTAAT3′), ζ57 (5′TGGAG GT
TAGTGCACACCACTTACCGCGTAAT3′), and ζ65 (5′T
GGAGGTTCCCCAGCCAGTGCACACGCGTAAT3′)
mRNAs were commercially sourced (IDT). Approximately
1 μg of each ssDNA was incubated overnight at 4°C in
500 μL cytoplasmic extract supplemented with 50 μL
ImmunoPure Avidin Agarose beads (Pierce). The pelleted
beads were washed 2× with PBS + Triton-×100 (0.05%)
and 2× with PBS + Triton-×100 (1.0%), resuspended in
10 μL loading buffer, and resolved on a precast 4-12% gra-
dient SDS-polyacrylamide gel (Invitrogen). Cytoplasmic
extracts were prepared from ~1×107 cells lysed in buffer
(1 mM Hepes pH 7.9, 0.15 mM MgCl2, 1 mM KCl) and
clarified by centrifugation at 13000xg for five minutes at
4°C; extract was stored in aliquots at −80°C.
Proteomics
Analyses were conducted by the University of Pennsylvania
Proteomics Core Facility. Tryptic digests were studied by
nanoLC/MS/MS using Thermo LTQ and Eksigebt nano
LC-2 Da instruments, and data analyzed from the Uni-
prot_Sprot database using Sequest and Scaffold software
packages. Statistical p-value cutoffs of 95.0% and 99.0%
were applied for peptides and proteins, respectively.
Western transfer
Antibodies were used at the following dilutions: AUF1
(kind gift of G Dreyfuss; 1:2000), replication protein A
(Santa Cruz SC-81373; 1:300), and hnRNP-H (Santa
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solved on precast 4-12% SDS-polyacrylamide gels, then
transferred to nitrocellulose using an XCell II Module per
manufacturer recommendations (Invitrogen). Membranes
were blocked for 30 minutes at room temperature (RT)
with Superblock T20 (Thermo Scientific), then supple-
mented with primary antibody for 60 min and with
secondary HRP-conjugated antibody for an additional
30 minutes. Immunoblots were washed thrice for five mi-
nutes at RT with PBS + Tween-20 (0.1%), and analyzed by
ECL chemiluminescence (GE Healthcare).
mRNA secondary structure
A DNA template for in vitro transcription of the ζWT 3′
UTR, containing an 18-nt polyadenylate tail, was direc-
tionally inserted into the XhoI-BglII polylinker site of
pSP72. The BglII-linearized plasmid was transcribed
in vitro as previously described [41], and the purified RNA
then 5′-end labeled with [γ-32P]ATP using a Kinase Max
kit (Ambion). The [32P]-labeled RNA was digested with
RNase A (100, 10, 1.0, and 0.1 ng/mL), RNase T1 (100, 10,
1.0, and 0.1 mU/μL), or RNase V1 (10, 1.0, 0.1, and
0.01 mU/μL) as directed by the supplier (Ambion). RN-
ases A and T1 exhibit cleavage specificities for pyrimidine
and guanosine bases in single-stranded regions of RNA,
respectively, while RNase V1 cleaves 3′ to nucleotides
within double-stranded regions of RNA. Reaction prod-
ucts were resolved on a 33 cm × 40 cm 6%:8 M acryl-
amide:urea gel, in parallel with a migration-control
‘ladder’ generated by alkaline hydrolysis of [32P]-labeled
transcripts [41].
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